Kineret
- Name: KINERET
- Generic Name: Anakinra
- Strength: 100 mg/0.67 mL solution for Subcutaneous Injection
- Manufactured: Swedish Orphan Biovitrum AB
Kineret (Anakinra 100 mg / 0.67 mL solution) is an interleukin-1 receptor antagonist used for:
Rheumatoid Arthritis (RA): Reduction in signs and symptoms and resisting the progression of structural damage in moderately to severely active rheumatoid arthritis, in patients aged 18 years or older who have failed single/multiple disease modifying antirheumatic drugs (DMARDs).
Cryopyrin-Associated Periodic Syndromes(CAPS): Treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID).
Kineret (Anakinra) is an FDA approved drug.
- Do not use kineret 100 mg in patients with known hypersensitivity to E coli-derived proteins, Kineret, or any other components of the product.
- Administration of Kineret injection in combination with TNF blocking agents is not recommended.
- Neutrophil counts should be assessed before initiating therapy with anakinra injection, and while on therapy, monthly for three months, and thereafter quarterly for a period up to one year.
- Treatment with anakinra drug should not be initiated in those patients who are with active infections.
What documents are required to import Kineret?
Kineret (Anakinra) injection can be imported by patients or government hospitals on behalf of patients. The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of the respective country).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is Kineret available worldwide?
Kineret (Anakinra) injection is a prescription pharmaceutical drug that legally requires a medical prescription for dispensation.
Urgent Meds facilitates the import of critical medications like Kineret globally, ensuring the named patient supply (NPS). Urgent Meds is the facilitator that provides essential support for:
- Availability of Kineret (Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka).
- Kineret Available in India (Noida, Delhi, Mumbai, Gurgaon, Lucknow, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and Pune, etc).
- Determining Medicine Price.
- Sourcing genuine and reliable sources from the USA, Canada, Europe, and Australia.
- Ensuring 100% transparency.
Kineret can be made available to patients, doctors, and hospitals in various countries across the globe. The order will be confirmed only after receiving a valid prescription from the doctor and, if required, an import permit.
Urgent Meds can facilitate the supply of Kineret (prescription medicine) to locations worldwide while adhering to legal requirements (if applicable).
We assure quality and worldwide delivery as per the buyer’s specifications.
Urgent Meds is able to source the Kineret (Anakinra) injection from across the globe and has the ability to supply. Urgent Meds offers its customers worldwide access to the best available treatment.
Urgent Meds is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Kineret®?
Anakinra is the Generic Name for the trade name drug Kineret®.
What is the Manufacturer Name of Kineret®?
Kineret® is manufactured by Swedish Orphan Biovitrum AB.
When and by whom was Kineret® approved?
Kineret® was approved by the FDA in 2001.
What is the dosage and form of Kineret® available?
Kineret® is available as a 100 mg/0.67 mL solution for Subcutaneous Injection.
What are the most commonly reported side effects of Kineret®?
The most commonly reported Kineret® side effects (incidence ≥ 5%) when used for Rheumatoid Arthritis (RA) are injection site reaction, upper respiratory tract infection, worsening of rheumatoid arthritis, headache, diarrhea, nausea, sinusitis, arthralgia, abdominal pain, and flu-like symptoms.
The most commonly reported anakinra side effects in the first 6 months of treatment (incidence >10%) when used for Cryopyrin-Associated Periodic Syndromes (CAPS) are headache, vomiting, injection site reaction, arthralgia, nasopharyngitis, and pyrexia.
What is the latest guidance on Kineret® for COVID-19?
Kineret® has been used in certain patients to treat COVID-19. For adults with severe COVID-19, the recommended dosage is 100 mg administered daily by subcutaneous injection for 10 days. However, it is crucial to follow your healthcare provider’s advice and continue other recommended preventive measures such as isolating, wearing a mask, and practicing hand hygiene.
Can Kineret® be used for pediatric patients?
Yes, Kineret® is used for pediatric patients, particularly those with Cryopyrin-Associated Periodic Syndromes (CAPS) and Deficiency of Interleukin-1 Receptor Antagonist (DIRA). For children aged one month and older, the initial dose is 1 to 2 mg/kg subcutaneously daily, with dose adjustments based on clinical response.
Is Kineret® available in Asia?
Kineret® (Anakinra) injection is available in Asian countries like Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka.
How can I get Kineret® injection?
Urgent Meds can facilitate the supply of Kineret® (prescription medicine) to locations worldwide while adhering to legal requirements.
Are there any special storage instructions for Kineret®?
Yes, Kineret® should be stored in the refrigerator between 36°F to 46°F (2°C to 8°C). Do not freeze the medication. If necessary, Kineret® can be kept at room temperature (below 77°F or 25°C) for up to 12 hours, but it should not be placed back in the refrigerator once it has reached room temperature.
Can Kineret® be used with other medications?
Kineret® can be used with other arthritis medications, such as methotrexate, steroids like prednisolone, and non-steroidal anti-inflammatory drugs (NSAIDs). However, it should not be used with TNF inhibitors like Enbrel®, Remicade®, or Humira®, due to an increased risk of infections.
What precautions should be taken before starting Kineret®?
Before starting Kineret®, inform your doctor if you have any infections, a history of tuberculosis (TB), or if you are taking other medications that affect the immune system. A TB test is often required before initiating treatment. Also, discuss any history of cancer or plans to become pregnant with your doctor.
Where is Kineret® available in India?
Kineret® is available in India (Noida, Delhi, Mumbai, Gurgaon, Lucknow, Kolkata, Hyderabad, Chennai, Ahmedabad, Bangalore, and Pune).
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.